investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Genetic Modifiers of Initiation and Progression of Mammary Cancer

Kent Hunter

3 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Thomas Keane

Wellcome Trust Sanger Institute (WT)

Saffron Walden, United Kingdom

David Adams

Wellcome Trust Sanger Institute (WT)

Saffron Walden, United Kingdom

Kent Hunter

National Cancer Institute (NIH)

Rockville, United States

Related projects

Rachelle W Johnson

Characterization of breast cancer dormancy in bone

Breast

Mien-Chie Hung

Nuclear EGFR in Cancer Cell Signaling and Radioresistance

Breast

Radiation Oncology

Jose Baselga

Unraveling resistance to PI3K-alpha inhibitors in breast cancer

Breast

Rohit Prakash

Deciphering the epistatic relationships of RAD51 Paralogs in mammary epithelium

Breast

Alvaro Monteiro

Charting the BRCT Domain Network

Breast

Theresa A Guise

Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth

Breast

Laura Alice Stransky

Elucidating the mechanism of mTORC1 activation by amino acids

Breast

Pathology

Lewis A Chodosh

Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence

Breast

Joe W Gray

Model-based Predictions of Responses RTK Pathway Therapies

Breast